Search results
Results from the WOW.Com Content Network
Baxter’s kidney-care operations generated about $4.5 billion in revenue last year and have more than 23,000 employees. “This transaction is the right step at the right time for Baxter, capping ...
Approximately 4 million people worldwide receive dialysis treatment for chronic kidney disease. 1 Access to this life-sustaining treatment varies across regions, and patients on dialysis often face physical and emotional burdens throughout the therapy process. Empowering patients and care teams, while helping to break down the barriers to ...
(Reuters) -Private equity firm Carlyle Group is in exclusive talks to acquire Baxter International's kidney care spinoff Vantive for more than $4 billion, including debt, a person familiar with ...
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois. [2] The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion (+2% vs 2022), across three business: "Medical Product and Therapies", "Heathcare ...
Baxter sold its BioPharma Solutions business in October for $4.25 billion to investment firms. The new company, Simtra, wants to expand. ... Workers can enter only after they take off their street ...
Gambro is a global medical technology company that manufactures products for dialysis treatment. The company is involved in developing, manufacturing and supplying products and therapies for kidney and liver dialysis, myeloma kidney therapy [clarify], and other extracorporeal therapies for chronic and acute patients.
Baxalta (Bax from the name of its former parent company; alta a Latin adjective meaning 'high' or 'profound' [2]) is a biopharmaceutical company founded on 1 July 2015 after its parent company, Baxter International, spun off biopharmaceutical division. [1]
Hospira was an American global pharmaceutical and medical device company with headquarters in Lake Forest, Illinois.It had approximately 19,000 employees. [1] Before its acquisition by Pfizer, Hospira was the world's largest producer of generic injectable pharmaceuticals, [2] manufacturing generic acute-care and oncology injectables, as well as integrated infusion therapy and medication ...